Glycopyrrolate
Glycopyrrolate Injection, USP
Approved
Approval ID
9c9666bf-841b-03fa-e053-2a95a90abb48
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 11, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Glycopyrrolate
PRODUCT DETAILS
NDC Product Code71872-7181
Application NumberANDA211334
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 11, 2023
Generic NameGlycopyrrolate
INGREDIENTS (5)
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
GLYCOPYRROLATEActive
Quantity: 0.2 mg in 1 mL
Code: V92SO9WP2I
Classification: ACTIB